Concepedia
Cancer Letters · 2011 · 100 citations · 17 references
MedicineOncologyPharmacologyMolecular OncologyNeoplasiaOncogenesCancer Cell SignalingGastric CancerOncogenic Signaling PathwaysP21 Regulation
17
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky, Hrvoje Šimić, Jurica Arapović et al. · Proceedings of the National Academy of Sciences · 2009 · 3.5K citations · Full text
Life Sciences, Immunology, Molecular Biology +16
An Isoform-Selective, Small-Molecule Inhibitor Targets the Autoregulatory Mechanism of p21-Activated Kinase
Sean Deacon, Alexander Beeser, Jami Fukui et al. · Chemistry & Biology · 2008 · 373 citations
Life Sciences, Molecular Biology, Pharmacology +14
PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia
Arie Abo, Jian Qu, Marta S. Cammarano et al. · The EMBO Journal · 1998 · 354 citations
Life Sciences, Cell Biology, Molecular Biology +14
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
Brion W. Murray, Chuangxing Guo, Joseph Piraino et al. · Proceedings of the National Academy of Sciences · 2010 · 321 citations · Full text
Medicine, Oncology, Pharmacology +15
Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines
Marinella Callow, Felix Clairvoyant, Shirley Zhu et al. · Journal of Biological Chemistry · 2002 · 307 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16